Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracochlear Platelet-rich Fibrin Application in Cochlear Implantation
NCT05215197Recruiting
- Sponsor
- Pamukkale University
- Start
- Jan 2022
- Primary completion
- Dec 2028
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
Open-label, single-arm trial of platelet rich fibrin in sensorineural hearing loss (SNHL), sponsored by Pamukkale University. Primary endpoint: Electrode Impedance at 6 months. Started Jan 2022; status: recruiting.
02
Drugs
platelet rich fibrin
03
Conditions
sensorineural hearing loss (SNHL)
Beyond the preview
Go deeper on NCT05215197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05215197.